The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2010

Filed:

Sep. 23, 2005
Applicants:

Cheol Kyu Han, Seoul, KR;

Jeonghyeok Yoon, Yongin-si, KR;

Nam-doo Kim, Incheon-si, KR;

Jin-ah Kim, Taejeon-si, KR;

Inventors:

Cheol Kyu Han, Seoul, KR;

Jeonghyeok Yoon, Yongin-si, KR;

Nam-Doo Kim, Incheon-si, KR;

Jin-ah Kim, Taejeon-si, KR;

Assignee:

Equispharm Co., Ltd, Daejeon, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed herein are 5,β-dimethylthieno[2,3-d]pyrimidine derivatives useful as antiviral agents. More particularly, disclosed are 5,β-dimethylthieno[2,3-djpyrimidine derivatives represented by Formula 1, having an excellent inhibitory effect on the proliferation of hepatitis C virus (HCV), pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the prevention and treatment of hepatitis C virus (HCV), containing, as active ingredients, these compounds. The 5,6-dimethylthieno[2,3-d]pyrimidine derivatives represented by Formula 1 have an excellent effect of inhibiting the proliferation of hepatitis C virus and also have low toxicity. Thus, these compounds are available as agents for the prevention and treatment of hepatitis C.


Find Patent Forward Citations

Loading…